GSK to study consumer health buys but pharma top priority

LONDON (Reuters) - GlaxoSmithKline will look at acquisition options to bulk up its consumer health business as rivals like Pfizer and Merck KGaA quit the field, but its top investment priority is bolstering prescription drugs.

from Reuters: Health News http://ift.tt/2y6likG